Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin | Zendy

Yasser Fouad | Zendy; Hanaa Mohamed Khalaf | Zendy; Hala Ibraheem | Zendy; Heba Rady | Zendy; Amal Helmy | Zendy

Open Access

Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin

Author(s) -

Yasser Fouad,

Hanaa Mohamed Khalaf,

Hala Ibraheem,

Heba Rady,

Amal Helmy

Publication year - 2011

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2011.09.022

Subject(s) - ribavirin , medicine , pegylated interferon , retinopathy , diabetic retinopathy , hepatitis c , diabetes mellitus , hepatitis c virus , visual acuity , incidence (geometry) , combination therapy , gastroenterology , surgery , immunology , virus , endocrinology , physics , optics

Data are scarce on ocular complications in Egyptian patients with chronic hepatitis C treated with pegylated interferon and ribavirin therapy. The aim of this study was to investigate the development of retinal lesions induced by interferon therapy for chronic hepatitis C.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research